Global Meeting on

Molecular & Cancer Biomarkers

Dubai, UAE   November 23-24, 2017

Biomarkers Meeting 2017

Dubai, UAE November 23-24, 2017

Theme: Latest discoveries and innovations in the field of Molecular and Cancer Biomarkers.

Cancer:

Genomics and Metabolic-Cancer genomics is the examination of the totality of DNA gathering and quality expression differentiates between tumour cells and customary host cells. It expects to grasp the genetic introduce of tumour cell extension and the advancement of the danger genome under change and assurance by the body condition, the insusceptible structure and accommodating intervention. The metabolites inside a cell or natural structure are being used to look at illness processing framework on a system wide scale, depicting the altered pathways and their associations with each other. Harm metabolomics incorporates creation examination by an extent of logical stages through centred/un targeted approaches. The utilisation of metabolomic towards development inspect has incited to a revived valuation for assimilation framework in tumor change and development.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Cancer Biomarkers:

A development biomarker is a part or strategy that demonstrates the closeness of illness in the body. A biomarker may be any molecule released by closeness a tumor or a specific indication of the body to the proximity of development. Development biomarkers are commonly characteristic iotas found in blood, other body fluids, or tissues that are an indication of a standard or bizarre process, or of a condition or contamination.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Clinical Biomarkers:

Biomarkers which are used for clinical aims are called clinical biomarkers. Clinical biomarkers close by Pathological biomarkers give a vivacious and influential way to deal with understanding the extent of various sicknesses with usages in judgemental and informative the investigation of malady transmission, self-emphatic clinical trials, screening for medicines or disease finding and expectation. Portrayed as changes in the constituents of cells or body fluids, these clinical biomarkers offer the strategies for regulated portrayal of an affliction and danger factors, and the can expand the base information about the shrouded pathogenesis of disease.

The essential asks about in clinical biomarkers are done in the fields of drug divulgence, oncology, pharmacogenomics and disease diagnostics. This biomarker meeting goes in understanding about these fields.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Cancer Therapy and Treatment

Cancer can be managed by different methods like Radiation Therapy; Bone Marrow Transplantation this treatment happens if there ought to be an event of leukemia lymphoma and myeloma. Hormone Replacement Therapy wherein the patient, over the traverse of helpful treatment, gets hormones, either to supplement a nonattendance of typically occurrence hormones, or to substitute distinctive hormones for really happening hormones. Surgery and Laparoscopy depicts the execution of surgical methodologies with the assistance of a camcorder and a couple thin instruments. Immuno therapy is a sort of illness treatment that helps safe structure against fight tumor.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Biomarkers in cancer detection:

Prognosis or response to therapy and the accessibility of fitting examine strategies. While a few markers give data on the nearness of tumor, others give data on the danger of creating disease or the probability of an individual reacting to a specific treatment. A few cases of biomarkers utilized as a part of growth research.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Biomarkers in Non-Cancerous Diseases:

Biomarkers arrange a critical part in different neurological and cardiovascular infections. The infections which are hopeless from ages are being offered a conceivable treatment and simple analysis with the assistance of progressions in biomarkers through various diagnostics and imaging innovations. Cardiovascular biomarkers and neuro biomarkers has acquired an awesome upheaval sickness analysis and program.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Cell Free Biomarkers:

Circulating Biomarkers allow for the possibility of early, non-invasive detection of cancers. They also represent highly sensitive biomarkers of submissive disease and are capable of reflecting tumor affliction and cancer changing aspects in the disease biomarkers gatherings, clinical, specialized, and natural parts of cell free biomarkers, and new advancements and procedures will be talked about. Unique consideration will be given to examine on clinical cases to further observe the sights of the uses of these biomarkers and forthcoming of cell free biomarkers in malady diagnostics.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Molecular Biomarkers Discovery:

Molecular biomarkers are molecules whose fixations in an organic framework advise about the current phenotypical state and, all the more essentially, may likewise be prescient of future phenotypic characteristic endpoints. The recognizable proof of biomarkers has increased much consideration in focused plant reproducing since advancements have turned out to be accessible that measure numerous particles crosswise over various levels of sub-atomic association and at diminishing costs. Protein biomarker revelation, Mass spectrometry based biomarker disclosure, Clinical investigation of NGS tests Biomarkers for pediatric sicknesses, new systems for revelation.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Biomarkers in Screening for Cancer:

Screening for premalignant sores or early intrusive infection can possibly decrease mortality from malignancy. As a result of their simplicity of estimation, a few biomarkers have been assessed or are at present experiencing assessment as screening tests for early harm. These incorporate the utilization of AFP in screening for hepatocellular malignancy in high-chance subjects, CA 125 in blend with transvaginal ultrasound (TVU) in screening for epithelial ovarian growth, PSA in screening for prostate tumor, fecal mysterious blood testing (FOBT) in screening for colorectal disease (CRC) and vanillymandelic corrosive and homovanillic corrosive in screening for neuroblastoma in babies, of these biomarkers, just the utilization of FOBT in screening for CRC has unequivocally been appeared to diminish mortality from growth.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Biomarkers in Breast Cancer: 

Identification of bosom growth at an early stage through a biomarker measure is critical to diminish the weight of illness since bosom malignancy distinguished at a before stage is significantly more reparable than metastatic infection. Subsequently, it is likewise important to distinguish biomarkers that may foresee the event of metastasis before it shows in the patient. In view of this necessity, a few potential biomarkers have picked up consideration and are portrayed beneath: 1. the mix of three autonomous biomarkers, including the urokinase-subordinate plasminogen activator framework (uPA), the plasminogen activator inhibitor (PAI) and the Thomsen-Friedenreich (TF) antigen for an early conclusion. 2. Mamma globin, osteopontin, snail, wind, Zeb-1, fibroblast development calculate receptors (FGFR), phosphatase and straining homolog (PTEN) and sirtuins (SIRT) are potential biomarkers for the expectation of metastatic sickness.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Genetic biomarkers:

Growth is a genetic illness started by modifications in genes, for example, oncogenes and tumor silencers that direct cell expansion, survival, and other homeostatic capacities. Pick up/loss of quality capacity are predominantly responsible for oncogenic change. A few proto-oncogenes get changed over into oncogenes with as little as a point transformation on a chromosome, in this way adjusting the measure of its item i.e., protein. A few non-arbitrary transformations, and translocations/revision inside the administrative district of the quality are additionally known to be related with specific sorts of danger.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

Biomarkers in lung cancer:  

Lung cancer is the main source of worldwide disease passing in both guys and females. As per the latest projection of worldwide mortality, by 2030 it will rise as the third and the fifth driving reason for death in high and center wage nations. Breath synthetic tests have an expansive range of utilizations extending from the US Food and Drug Administration-endorsed breathed out nitric oxide division (FeNO) estimation to screen the impact of calming treatment in asthma, to unstable natural compound (VOC) assurance and nonvolatile biomarker profiling in the cooled breath test called breathed out breath condensate.

2nd Annual Biomarkers and Precision Medicine Congress, 9-11 October 2017, San Deigo, USA;  10th World Congress on Biomarkers and Clinical Research, 18-20 October 2017, Baltimore, USA;  9th International Conference on Biomarkers, 26-28 October 2017, Osaka, Japan;  Global Summit on Clinical Research and Biomarkers, 21-23 August 2017, Dallas, USA; International Conference on Biomarkers and Clinical Research, 29-30 November 2017, Atlanta, Georgia, USA;  9th World Biomarkers Congress, 7-8 December 2017, Madrid, Spain;  13th Annual Biomarkers Congress, 15-16 February 2018, Manchester, UK.

 

Global Experts Meeting On Molecular & Cancer Biomarkers which will be held from 23-24, November 2017 at Dubai UAE unites an extraordinary and worldwide blend of expansive and medium pharmaceutical, biotech and demonstrative organizations, driving colleges and clinical research establishments making the meeting an immaculate stage to share understanding, encourage coordinated efforts crosswise over industry and the scholarly world, and assess developing advances over the globe.  Biomarker Meeting 2017 will likewise give the three days of dialogs on techniques and methodologies identified with administration and quality change of Diagnostics gadget creating and Cancer Research and additionally to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung disease, bosom tumor, bone malignancy, leukemia, blood growth, cervical tumor, colon-rectum growth, Pediatric malignancy, surgical disease, Prostate malignancy, thyroid disease.

Biomarker Meeting manages investigation of fundamental explores in the field of malignancy and oncology. It includes recognizing causes and to create methodologies for analysis, counteractive action, treatment and cure for this shocking sickness. Biomarker Meeting 2017 is the essential occasion that unites an extraordinary and worldwide specialists, scientists and chiefs both from the scholarly community and industry over the world to trade their insight, aptitude and research developments in the field of malignancy treatment. Amid the entry of the three day meeting, you can benefit chance to both system and see pioneers from the worldwide scholarly and corporate malignancy inquire about groups.

Importance and Scope:

International and Cancer Biomarkers is the best anticipated conference. It is the best way to collaborate with industry peers and discover knowledge and resources. This is the best opportunity to reach the largest assemblage of participants from the biomarkers community. This is the best platform for all the oncologists, scientists, students, research scholars who are well reputed in this field. This international event is the demand for new biomarkers in different applications has boosted the biomarkers market.

Meetings International warmly invites all the Eminent personalities, Reputed Scientists and Speakers, Industry Professionals, Healthcare and Academic Professionals from the Healthcare and Oncology field to share their thoughts and methodologies in this International event. This will bring a good result. It is open to all types of research methodologies both from academic and industry.

Why Dubai:

Dubai is the most popular city in the United Arab Emirates (UAE). It is located on the southeast coast of the Persian Gulf and is the capital of the Emirate of Dubai, one of the seven emirates that make up the country. Abu Dhabi and Dubai are the only two emirates to have veto power over critical matters of national importance in the country’s legislature. Dubai has emerged as a global city and business hub of the Middle East. It is also a major transport hub for passengers and cargo. The city of Dubai is located on the emirate's northern coastline and heads the Dubai-Sharjah-Ajman metropolitan area. Dubai will host World Expo 2020. Dubai has emerged as a global city and business hub of the Middle East. It is also a major transport hub for passengers and cargo. Dubai's hotel rooms were rated as the second most expensive in the world, after Geneva. Dubai was rated as one of the best places to live in the Middle East by U.S. global consulting firm Mercer.

 Conference Highlights:

Cancer

Cancer Biomarkers

Clinical Biomarkers

Cancer Therapy and Treatment

Biomarkers in Cancer detection

Biomarkers in Non-Cancerous diseases

Cell Free Biomarkers

Molecular Biomarkers Discovery

Biomarkers in Screening for Cancer

Biomarkers in Breast Cancer

Genetic Biomarkers

Biomarkers in Lung Cancer

Who to attend:

With individuals around the globe concentrated on finding out about Molecular and Cancer Biomarkers; this is your best chance to achieve the biggest gathering of members from the Biomarkers and Clinical Research people group. Direct presentations, circulate data, meet with present and potential researchers, make a sprinkle with cutting edge medicines, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest procedures, advancements and the most current upgrades in Molecular and Cancer Biomarkers are the signs of this gathering.

Major Associations around the World:

Association for International Cancer Research

Association of Oncology Social Work

 Austrian Cancer Society

Bulgarian Cancer Association

Canadian Cancer Association

German Cancer Society

Italian Cancer Association

Japan Lung Cancer Society

National Cancer Institute of Argentina

American Society of Clinical Oncology

Asian Society of Neuro-Oncology

Association of Cancer Physicians

Association of Oncology Social Work

Belgian Association of Oncological Radiotherapy

Brain Tumor Foundation of Canada

Bolivian Society of Oncology

Canadian Association of Pharmacy in Oncology

Cancer Association of Namibia

Cancer Association of South Africa

Canadian Association of Radiation Oncology

Cancer Research UK

Cancer Society of Nepal

Cancer Society of Brazil

Cancer Society of Finland

Cancer Society of New Zealand

American Association for Cancer Research

Association of Community Cancer Centers

Cancer Research Foundation

Cancer Council Austria

Dutch Cancer Society

Egyptian Cancer Society

Indonesian Society of Gynecologic Oncology

International Association of Cancer Registers

Jamaican Cancer Society

Jordon Cancer Society

Japanese Breast Cancer Society

Kidney Cancer Association

Korean Cancer Association

Lung Cancer Foundation of America

National Cancer Institute of Colombia

National Cancer Registrars Association

National Health and Medical Research Council

Prostate Cancer Foundation

Prostate Cancer UK

Saudi Cancer Society

Saudi Oncology Society

Skin & Cancer Foundation Australia

Society for Neuro-Oncology

Spanish Association Against Cancer

Swiss Cancer League

Uganda Child Cancer Foundation

Union for International Cancer Control

United Kingdom Association of Cancer Registries

Victorian Cancer Registry

World Federation of Surgical Oncology

World Health Organization- Africa Region

European Society for Medical Oncology

European Cancer organization

German Cancer Aid

Indian Cancer Society

Institute of Cancer of Sao Paulo

Israel Cancer Research Fund

Manchester Cancer Research Center

Peruvian Cancer Foundation

Swiss Cancer Center

Esophageal Cancer Awareness Association

Swedish Cancer Society

 Spanish Oncology Nursing Society

Society for Immunotherapy of Cancer

American Brain Tumor Association

Association of Community Cancer Centers

Australian Cervical Cancer Foundation

Australian Prostate Cancer Research

Bermuda Cancer and Health Center

Bladder Cancer Canada

British Gynecological Cancer Society

Canadian Breast Cancer Research Alliance

Canadian Society for Surgical Oncology

Cancer Society Venezuela

Chinese Society of Clinical Oncology

Cyprus Anti-Cancer Society

Foundation for Women’s Cancer

French Cancer Society

French Association of Oncology Nurses

French Society of Radiation Oncology

German Society of Radiation Oncology

Hellenic Cancer Society

Hellenic Society of Medical Oncology

Hong Kong Neuro-Oncology Society

Iranian Society of Radiation Oncology

International Liver Cancer Association

Joseph Carreras Leukemia Foundation

Lebanese Cancer Association

National Cancer Society of Malaysia

National Cancer Registry- Ireland

Romanian Cancer League

Portuguese Cancer League

Philippine Society of Medical Oncology

Ovarian Cancer Australia

Neuroblastoma Canada

Top Industries Associated:

Roche

Novartis

Celgene

Johnson & Johnson

Bristol-Myers Squibb

Lilly

Takeda

AstraZeneca

Merck & Co.

Amgen

Pfizer

Astellas

Bayer

Otsuka

Sanofi

Merck KGaA

Eisai

Abbott Laboratories

AbbVie

Pharmacyclics

Incyte

Seattle Genetics

Alkermes

Jazz Pharmaceuticals

Dr. Reddy’s Laboratories

Valeant Pharmaceuticals International

Perrigo

Sinopharam Group

UCB

BioMarin Pharmaceuticals

Actelion

Mylan

Vertex Pharamaceuticals

Alexion Pharamaceuticals

Sun Pharamaceuticals Industries

CSL

Regeneron Pharamaceuticals

Teva

Shire

Biogen

Allergan

Gilead Science

Novo Nordisk

Gilead Sciences

Glidewell Laboratories

Glaxo SmithKine

Lupin Ltd

Henry Schein

Omnia LLC

Ranbaxy

RaySearch Laboratories

Piramal Healthcare

Sanofi

Sonifi FRA

Zimmer Dental

Boehringer Ingelheim

Astra Zenca

Bio Horizons

Biomarkers Pharamaceuticals Inc

Celldex Therapeutics

Clovis Oncology

Dendreon

DenMat

DentistrylQ

DENTRIX Ascend

DENTSPLY Implants

Eli Lilly & Co USA

OralCDx

OrallD

PATTERSON Dental

Pfizer USA

Top Audience at Oncology Conferences:

Cancer Research Students, Scientists

Cancer Researchers

Cancer research Faculty

Medical Colleges

Cancer Associations and Societies

Oncologists

Radiologists

Chemotherapists

Pathologists

Physicians

Business Entrepreneurs

Medical Devices Manufacturing Companies

Pharmaceutical Companies

Diagnostics Companies 

Market Analysis Report:

The global biomarkers market is estimated to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, at a CAGR of 13.8% from 2016 to 2021.

The biomarkers market is segmented on the basis of product, type, application, disease indication and region.

On the basis of product, the market is segmented into consumables, services and software. The consumables segment is estimated to account for the largest share of the global market in 2016. The large share of this segment is primarily attributed to the lower price of consumables than that of screening and automation instruments.

Growth in the market is mainly driven by factors such as increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies. 

Market Analysis Insights:

The global cancer biomarkers market has experienced substantial growth over the last couple of years. This market is expected to grow at a CAGR of 11.6% from 2015 to 2020. Factors such as rising incidence of cancer; technological advancements in omics technologies; favorable government funding for cancer research; increased demand for personalized medicines in cancer therapies; and increased use of biomarkers in drug discovery development and clinical trials are expected to fuel the growth of the cancer biomarkers market during the forecast period. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

  • Cancer
  • Cancer Biomarkers
  • Clinical Biomarkers
  • Cancer Therapy And Treatment
  • Biomarkers in cancer detection
  • Biomarkers In Non Cancerous Diseases
  • Cell Free Biomarkers
  • Molecular Biomarkers Discovery
  • Biomarkers In Screening For Cancer
  • Biomarkers in Breast Cancer
  • Genetic biomarkers
  • Biomarkers in lung cancer